Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

ViroPharma Announces Publication of Cinryze(TM) (C1 Esterase Inhibitor [Human]) Phase 3 Trial Result
PR-USA.net
Saturday, August 7, 2010 - 12:57pm
tags:
ViroPharma, Cinryze, C1 esterase inhibitor, hereditary angiodema
Response Genetics total revenue for second-quarter 2010 increases 197% to $5.6 million
News-Medical.net
Saturday, August 7, 2010 - 12:48pm
tags:
Response Genetics, earnings, investors
GSK says image of new antibiotic in action opens up new opportunities to combat antibacterial resistance
Pharmabiz
Saturday, August 7, 2010 - 12:44pm
tags:
GSK, antibiotics
Chinese patent traditional medicine first time passes U.S. FDA crucial clinical trials
Xinhua
Saturday, August 7, 2010 - 12:43pm
tags:
cardiovascular disease, China
Synthetech first-quarter fiscal 2011 revenue decreases 56% to $2.0 million
News-Medical.net
Saturday, August 7, 2010 - 12:41pm
tags:
Synthetech, earnings, investors
Premiers join forces on health care (in Canada)
Toronto Sun, Canada
Saturday, August 7, 2010 - 12:38pm
tags:
Canada
Unusual Trading Activity for Medicis Pharmaceutical Corp. (MRX)
Market Intellisearch
Saturday, August 7, 2010 - 12:36pm
tags:
Medicis, investors
Merck Under Investigation for Potential FCPA Violations
Main Justice
Saturday, August 7, 2010 - 12:35pm
tags:
Merck, legal, SEC
Abbott Labs CEO Says He Walks A Tightrope
Yahoo/Investors Business Daily
Saturday, August 7, 2010 - 12:07pm
tags:
Abbott Laboratories
Auxilium Misses Expectations
Yahoo/Zacks
Saturday, August 7, 2010 - 12:06pm
tags:
Auxilium, earnings, investors
CyDex Pharmaceuticals licenses compound that could expand market reach Read more: CyDex Pharmaceuticals licenses compound that could expand market reach - Kansas City Business Journal
bizjournals
Saturday, August 7, 2010 - 11:59am
tags:
CyDex Pharmaceuticals, Captisol, Pfizer, Bristol-Myers Squibb, Prism Pharmaceuticals
Show Me the Money, AstraZeneca
Motley Fool
Saturday, August 7, 2010 - 11:55am
tags:
AstraZeneca
FDA Dings Novartis for Facebook Widget
WSJ
Saturday, August 7, 2010 - 11:54am
tags:
Novartis, FDA
Onyx Reports Wider Loss
Yahoo/Zacks
Saturday, August 7, 2010 - 11:53am
tags:
ONYX Pharmaceuticals, investors, earnings
Flu vaccine developer Novavax takes bigger 2Q loss
Yahoo/AP
Saturday, August 7, 2010 - 11:51am
tags:
Novavax, earnings, investors
Opexa Therapeutics Reports Second Quarter 2010 Financial Results
Yahoo/BusinessWire
Saturday, August 7, 2010 - 11:51am
tags:
Opexa, earnings, investors
Acne products boost Medicis Pharma's 2Q earnings
Yahoo/AP
Saturday, August 7, 2010 - 11:48am
tags:
Medicis, Solodyn, Triaz, Ziana, acne, dermatology, earnings, investors
Hemispherx Biopharma, Inc. 2nd Quarter 2010 Financial Results
Yahoo/GlobeNewsWire
Saturday, August 7, 2010 - 11:45am
tags:
Hemispherx, earnings, investors
Amylin Pharmaceuticals: Warming Up or Cooling Off?
Motley Fool
Saturday, August 7, 2010 - 11:44am
tags:
Amylin, investors
Osiris swings to 2Q profit
bizjournals.com
Saturday, August 7, 2010 - 11:42am
tags:
Osiris Therapeutics, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.